Lessons Learned from a Personalized CRISPR Gene Editing Therapy
Dr. Kiran Musunuru, MD, PhD, Barry J. Gertz Professor for Translational Research, Perelman School of Medicine, University of Pennsylvania
#CRISPR #geneediting #genetherapy #patienttherapies #interventionalgenetics
Why this is critically important to the gene editing / oligonucleotide industry
Personalized gene editing therapies are moving from concept to clinic, are you prepared? Dive into the journey of a single individual receiving a personalized CRISPR therapy to discover a practical view into the translational challenges of bringing these therapies to patients. You’ll learn from a true pioneer what considerations to be mindful of, bottlenecks that may stunt your progress, and real-world implications of interventional genetics. This is your chance to delve deeper into an expanding, evolving field of standard-of-care applications. Get an edge on your competitors and learn how to accelerate your path to market with the patient front-of-mind.
How will it help your career?
Front row seats to Dr. Musunuru on putting translational research into practice so you can better understand operational and regulatory considerations (and realities) of personalized gene editing. This is your opportunity to connect the early-stage research with clinical applications, providing you with the tools to strategize effectively. You’ll walk away with the ability to anticipate the evolving standards for interventional genetics and its implications on therapy design, safety, and patient access.
Ideal for those working in; research and development, translational medicine, clinical operations, regulatory affairs, and quality assurance.
Learn how cutting-edge science moves from the lab into the clinic with tangible insight on an individual’s journey.
